Alzheimer's disease is a progressive, irreversible neurodegenerative disease impacting
cognition, function, and behavior. Alzheimer's disease progresses along a continuum from …

Several potential disease-modifying drugs for Alzheimer's disease (AD) have failed to show
any effect on disease progression in clinical trials, conceivably because the AD subjects are …

Abstract Background The Montreal Cognitive Assessment (MoCA) was developed to enable
earlier detection of mild cognitive impairment (MCI) relative to familiar multi-domain tests like …

For half a century, it has been known that some patients experience neurocognitive
dysfunction after cardiac surgery; however, defining its incidence, course, and causes …

Alzheimer's disease (AD) is a neurodegenerative disorder that develops for years before
clinical manifestation, while mild cognitive impairment is clinically considered as a …

Aging can result in major changes in the composition and metabolic activities of bacterial
populations in the gastrointestinal system and result in impaired function of the immune …

Salivary analysis is gaining increasing interest as a novel and promising field of research for
the diagnosis of neurodegenerative and demyelinating diseases related to aging. The …

Context: Although both overt hyper-and hypothyroidism are known to lead to cognitive
impairment, data on the association between subclinical thyroid dysfunction and cognitive …

Background Most patients with dementia or cognitive impairment receive care from family
members, often untrained for this challenging role. Caregivers may not access publicly …

The guidelines on hypertension recently published by the European Societies of
Hypertension and Cardiology, have acknowledged cognitive function (and its decline) as a …